The purpose of study is to evaluate the efficacy of tranexamic acid in controlling bleeding
in patients of hemoptysis and also to evaluate the safety of tranexamic acid.
Drug: Tranexamic Acid
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT02781597
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Acute ongoing hemoptysis
Age: 18 years and above
Females on oral contraceptives
Patients on antifibrinolytics
Patients with known drug allergy
Patients with renal failure
Patients requiring intubation during study period
Patients with Massive hemoptysis (>600 ml/24 hrs)
All locations for NCT02781597
Post graduate institute of medical education and research
Chandigarh, UT, India, 160012
View full eligibility
Tris trial is registered with FDA with number: NCT02781597. The sponsor of the trial is Postgraduate Institute of Medical Education and Research and it is looking for 66 volunteers for the current phase.
Official trial title: Efficacy of Tranexamic Acid in Controlling Hemoptysis, A Randomized Control Trial
Thank you for applying!
We'll contact you soon with more information.
FindMeCure is constantly improving its search. Take part in it and help millions by filling our patients' survey!